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A small GTPase, Rho, plays key roles in cell adhesion, motility, and
contraction after stimulation. Among Rho effectors isolated, the
family of Rho-associated coiled-coil–forming protein kinases (ROCK)
is implicated in Rho-mediated cell adhesion and smooth muscle con-
traction. The effect of a specific inhibitor of ROCK, Y-27632, was
evaluated in a murine model of acute lung injury induced by intrave-
nous injection of Escherichia coli endotoxin (lipopolysaccharide [LPS]).
Lung edema was evaluated by measuring extravascular leakage of
radio-labeled serum albumin, and neutrophil emigration into the
lung parenchyma by morphometric observation and measuring my-
eloperoxidase activity. Pretreatment with Y-27632 attenuated both
lung edema and neutrophil emigration after LPS. We also measured
albumin transfer through cultured endothelial cell monolayers on
a porous filter. Tumor necrosis factor- significantly increased albu-
min transfer, which was attenuated by pretreatment with Y-27632.
Fluorescence microscopy revealed that morphologic changes in en-
dothelial cells induced by tumor necrosis factor- were inhibited
by Y-27632. In contrast, the increased fraction of neutrophils with
polymerized actin after formyl-methionyl-leucyl-phenylalanine was
not altered by Y-27632. These data suggest that ROCK may play
an important role in the pathogenesis of LPS-induced lung injury
and that ROCK inhibition could attenuate cytoskeletal rearrange-
ment of endothelial cells, leading to decreased neutrophil emigra-
tion into the lung parenchyma.
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Acute respiratory distress syndrome (ARDS) is a critical illness,
which is characterized by acute lung injury leading to permeabil-
ity pulmonary edema and respiratory failure (1, 2). Circulating
neutrophils play a major role in the development of acute lung
injury in both clinical settings and experimental animal models
(3, 4). Neutrophil sequestration into the pulmonary microvascu-
lature and migration into the lung parenchyma are critical steps
in the pathogenesis of acute lung injury, which is thought to be
induced by inflammatory mediators binding to specific receptors
on neutrophils and endothelial cells (4, 5). Previous studies sug-
gest that the sequestration of neutrophils occurs through at least
two sequential events (4, 6, 7). The first event is a rapid stiffening
of neutrophils, which occurs during the first few minutes after
an inflammatory mediator enters the bloodstream. Neutrophil
stiffening depends upon the polymerization of globular (g) actin
to filamentous (f) actin to form an actin-rich rim beneath the
plasma membrane (5, 8). The second event is firm adhesion
mediated by CD11/CD18 and other adhesion molecules, which
is necessary to maintain the sequestered neutrophils within the
capillaries (3, 4). This firm adhesion is followed by transendothe-
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lial migration into the lung parenchyma, leading to neutrophil-
mediated tissue injury.
Rho is a monomeric, 21-kD GTPase that exists in at least
three isoforms in mammals (Rho A, Rho B, and Rho C), which
increases cell adhesion, formation of actin stress fibers, and cell
contraction after thrombin stimulation (9–11). In cells other than
leukocytes, Rho activity is required for the formation of actin
stress fibers (10). In human neutrophils, Rho plays an important
role in signaling for myosin light chain phosphorylation and cell
migration (12). Among Rho effectors isolated, the family of
Rho-associated coiled-coil–forming protein kinases (ROCK) is
implicated in Rho-mediated cell adhesion and smooth muscle
contraction (13, 14).
Y-27632 is a selective ROCK inhibitor, which has been shown
to act as a bronchodilator and vasodilator through relaxation of
smooth muscle (15–18). To determine the role of Rho/ROCK
in the pathogenesis of acute lung injury, we investigated the
effect of Y-27632 on lipopolysaccharide (LPS)-induced acute
lung injury using a murine model. Lung edema was evaluated
by measuring extravascular leakage of radio-labeled albumin,
and neutrophil emigration into the lung parenchyma by morpho-
metric observation. We also measured albumin transfer through
cultured endothelial cell monolayers on a porous filter and evalu-
ated the effect of Y-27632 on the changes in albumin transfer
after TNF- stimulation. Confocal microscopy was performed
to examine the effect of Y-27632 treatment on morphologic
changes in endothelial cells and neutrophils induced by tumor
necrosis factor (TNF)- and fMLP, respectively.
MATERIALS AND METHODS
Animals and Antibodies
C57BL/6 mice, 8–11 wk old, were purchased from CLEA Japan (Tokyo,
Japan). All mice were housed in the Keio University Animal Resource
Center, and all experiments received institutional approval, conforming
to NIH guidelines. A ROCK inhibitor, Y-27632, was kindly provided
by Mitsubishi Pharma Corporation (Osaka, Japan). Escherichia coli
endotoxin (serotype B:55) and fMLP were purchased from Sigma
Chemicals (St. Louis, MO). Recombinant human TNF- was obtained
from PeproTech, Inc. (Rocky Hill, NJ).
Protocol 1: Effect of Y-27632 on LPS-Induced
Acute Lung Injury
Thirty-two C57BL/6 mice were divided into four groups: Group 1 was
given an intraperitoneal injection of 200 l of phosphate-buffered saline
(PBS) before intravenous injection of PBS (50 l); Group 2 received
Y-27632 (10 mg/kg given as a solution of 1.1 mg Y-27632/ml PBS)
before intravenous PBS; Group 3 received intraperitoneal injection of
PBS followed by intravenous injection of E. coli LPS (3 mg/kg given as
a solution of 1.2 mg LPS/ml PBS); Group 4 was treated with Y-27632
before LPS challenge. Mice were anesthetized using ketamine hydro-
chloride (80–100 mg/kg intramuscularly) and acepromazine maleate
(5–10 mg/kg intramuscularly) and received intravenous injection of
125I-labeled bovine albumin (0.1 mCi/mouse) to measure edema. Either
PBS or LPS was injected intravenously 20 min after intraperitoneal
injection of PBS or Y-27632. Blood samples were collected by orbital
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sinus puncture immediately before and 15 min after intravenous injec-
tion. Two minutes before the end of the study, 131I-labeled human
albumin (0.1 mCi/mouse) was injected to measure the intravascular
blood volume. After 6 h, the lungs were removed and fixed using
intratracheal instillation of 6% glutaraldehyde at 22 cm H2O. Blood
samples were obtained from the orbital sinus (time 0 and 15 min) and
inferior vena cava (6 h). White blood cells (WBC) were counted using
a hemocytometer, and differentials were determined using blood smears
stained with Diff-Quik (American Scientific Products, McGraw, IL).
Edema formation in lungs was evaluated by quantitating the accu-
mulation of extravascular albumin (EVA) as previously described
(7, 19). The isotope-specific radioactivity of excised, fixed lungs as
well as samples of blood and plasma was measured (ARC-300; Aloka,
Tokyo, Japan) before sectioning the lungs for morphometric analysis.
Blood and plasma volumes of lungs were determined from 125I-albumin
and 131I-albumin counts, respectively. Pulmonary edema (EVA in lungs)
was calculated as total lung albumin content minus intravascular lung
albumin content. Intravascular lung albumin content was calculated
from the pulmonary blood volume and the hematocrit for each animal.
Pulmonary neutrophils were quantified by morphometric analysis
in histologic sections (20). Paraffin-embedded histologic 5-m sections
of lungs were cut and stained with hematoxylin and eosin. Neutrophil
emigration was quantitated by counting the number of neutrophils in
200 randomly selected alveoli and was expressed as the number of
neutrophils per 100 alveoli.
In separate experiments, the neutrophil accumulation within the
lungs was evaluated by measuring the myeloperoxidase (MPO) activity
of lung tissue samples, following a previously reported method (21).
Twenty-four C57BL/6 mice were divided into four groups as described
above and killed 6 h after intravenous injection of either PBS or LPS.
After lungs were perfused via the right ventricle with 3 ml of sterile PBS,
the lungs were snap-frozen in liquid nitrogen and stored at 70 C. After
weighing, whole lungs were homogenized in 0.5% hexadecyltrimethylam-
monium bromide in 50 mM potassium phosphate buffer (pH 6.0) in an
ice bath. The specimens were freeze-thawed three times, after which son-
ication was repeated. Suspensions were then centrifuged at 40,000  g
for 30 min at 4C. Then 0.1 ml of supernatant was combined with
2.9 ml of 50 mM potassium phosphate buffer (pH 6.0) containing
0.167 mg/ml of o-dianisidine dihydrochloride and 0.0005% hydrogen
peroxide. The enzymatic activity was determined spectrophotometri-
cally as the change in absorbance at 460 nm over 5 min using a 96-well
plate reader (Molecular Devices, Sunnyvale, CA). MPO activity is
expressed per gram of lung weight.
Protocol 2: Effect of Y-27632 on Neutrophil Cytoskeleton
Human neutrophils were isolated from peripheral blood of healthy
volunteers using a two-step density gradient of Histopaque 1077 and
1119 (Sigma Chemicals) as previously described (22). The neutrophil
purity was  95%. The isolated neutrophils were fixed in the presence
of 10% paraformaldehyde for 2 min after treatment with fMLP or PBS.
Neutrophils were then permeabilized with 0.2 mg/ml of lysophosphati-
dylcholine, and stained with 0.33 M rhodamine-labeled phalloidin for
60 min to label filamentous actin (F-actin) (23). After staining, the
neutrophils were examined using fluorescence microscopy. Two hun-
dred randomly selected neutrophils were observed, and neutrophil
cytoskeletal rearrangement was quantitatively expressed as the percent-
age of neutrophils containing a submembrane rim of F-actin. Confocal
microscopy was performed to compare the structure of the F-actin rim.
Protocol 3: Effect of Y-27632 on Endothelial Cell Damage
Induced by TNF-
Human pulmonary artery endothelial cells (HPAECs) were obtained
from Kurabo (Osaka, Japan) at the fourth passage. HPAECs were
cultured in a humidified 5% CO2 atmosphere in the medium provided
by the manufacturer (HuMedia; Kurabo) supplemented with 2% fetal
calf serum and used for the experiments between the sixth and seventh
passage. Endothelial cell monolayers on filters were prepared as pre-
viously described (24). In brief, Millicell-HA tissue culture plate well
inserts (Millipore Co., Bedford, MA) were incubated with bovine fi-
bronectin at 37 C for 3 h to facilitate cell attachment. The fibronectin
solution was aspirated, and the endothelial cells suspended in the culture
medium were seeded on a membrane filter at a density of 4  105 cells/
filter insert. The inserts were placed into a 6-well culture plate, where
each well was filled with 2 ml of culture medium and incubated at 37 C
in a humidified 5% CO2 atmosphere. After 2 wk of culture, HPAECs
were found to reach confluence on the filter, and permeability measure-
ments and morphologic analyses were performed.
As an index of permeability, we measured the albumin transferred
across a cultured endothelial cell monolayer on a porous filter. HPAECs
on the filter were pretreated with 0.1, 1, 10, and 100 M of Y-27632
for 30 min and then incubated with 102 U/ml of TNF- for 6 or 24 h.
We aspirated the TNF- solution and added 500 l of PBS containing
0.1% bovine albumin to the upper chamber (i.e., the filter well insert).
The insert was then placed in 1 well of a 24-well culture plate, in which
each well was filled with 0.7 ml of PBS alone. The solution in the well
surrounding the filter insert occupied the lower chamber. The above
fluid volumes resulted in equal levels of fluid in the upper and lower
chambers and eliminated difference in hydrostatic pressure. After incu-
bation for 20 min, the insert was removed from the well. The albumin
concentration of the lower chamber was measured with a Bio-Rad
Protein Assay kit (Bio-Rad, Hercules, CA). To evaluate the effect of
Y-27632 on unstimulated endothelial cells, albumin transfer was mea-
sured across monolayers that were pretreated with 100 M Y-27632 for
30 min and then incubated with PBS for 6 or 24 h.
Morphologic analysis was also performed to assess the changes in
the actin microfilament cytoskeleton of endothelial monolayers. Mono-
layers, which were unstimulated, stimulated with 103 U/ml of TNF-, or
pretreated with Y-27632 (100 M) before TNF- exposure for 24 h,
were stained with rhodamine-phalloidin as previously described (25).
After staining, the monolayers were examined and photographed us-
ing a fluorescence microscope equipped with epi-illumination (Nikon
Optiphot; Nikon, Garden City, NY).
Statistics
Data are presented as mean  SEM. One-way ANOVA and Fisher’s
least-significant difference test were used. Differences were considered
statistically significant when P  0.05.
RESULTS
Pulmonary Edema Formation
Lung EVA was estimated 6 h after injection of saline or LPS
(Figure 1). LPS induced a significant increase in EVA (P 
0.001), and Y-27632 partially attenuated this increase (P  0.05).
There was no significant difference in EVA between the two
groups that received saline injection with or without Y-27632
pretreatment.
Neutrophil Emigration in Alveolar Spaces
To evaluate the effect of Y-27632 on LPS-induced neutrophil
emigration, emigrated neutrophils were quantified morphologi-
cally in histologic sections (Figures 2A and 2B). The number of
Figure 1. Edema formation 6 h after intravenous LPS injection. Lung
edema was determined by the leakage of radio-labeled albumin. Mice
received an intraperitoneal injection of either PBS or Y-27632. Regardless
of Y-27632 treatment, mice administered LPS revealed increased EVA
(*P  0.01). Pretreatment with Y-27632 significantly decreased edema
formation after LPS injection (#P  0.05) (n 	 8 in each group).
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neutrophils per 100 cross-sectioned alveolar spaces is shown
in Figure 2B. Pretreatment with Y-27632 inhibited neutrophil
emigration induced by LPS. Neutrophil emigration was less in
mice pretreated with Y-27632 (1,442  48 neutrophils/100 alve-
oli) compared with mice pretreated with intraperitoneal PBS
(1,587  36 neutrophils/100 alveoli, P  0.05).
MPO activity was measured to evaluate the total neutrophil
accumulation within the lungs (Figure 2C). MPO activity in
the mice administered LPS without Y-27632 pretreatment was
significantly elevated compared with that of the control group
(P  0.01). Y-27632 pretreatment significantly attenuated the
increase in lung MPO activity induced by LPS (P  0.05). There
was no significant difference in MPO activity between the control
and LPS
Y-27632 groups.
Peripheral Neutrophil Count
Peripheral neutrophil counts were determined at time 0, 15 min,
and 6 h after injection (Figure 3). In mice that received intravenous
LPS, the neutrophil count was markedly decreased at 15 min
and had almost recovered by 6 h. At 6 h, the neutrophil count
was increased in the control and Y-27632 groups as compared
with time 0. In mice that received LPS, the neutrophil count
was less than that in mice without LPS challenge at 6 h. There
was no difference in neutrophil counts between mice with and
without Y-27632 pretreatment at any time point.
Morphologic Changes in Stimulated Neutrophils
Neutrophil cytoskeletal rearrangement after fMLP stimulation,
which was expressed as the percentage of neutrophils containing
an F-actin rim, is shown in Table 1. Among the control neutro-
Figure 2. Neutrophil emigration 6 h after
instillation. (A ) Representative example of
lung pathology. No significant neutrophil
emigration was observed in the control
mice and the mice with Y-27632 treatment
followed by PBS instillation. Marked neu-
trophil emigration was caused by intratra-
cheal LPS, which was attenuated by the
pretreatment with Y-27632. (B ) Neutrophil
emigration was quantitated by counting
the number of neutrophils in 200 randomly
selected alveoli and was expressed as the
number of neutrophils per 100 alveoli.
Regardless of Y-27632 treatment, mice
administered LPS revealed increased neu-
trophil emigration (*P  0.01). Pretreat-
ment with Y-27632 significantly decreased
the neutrophil emigration after LPS injection
(#P  0.05) (n 	 8 in each group). (C ) Lung
MPO activity. Optical density at 460 nm
of homogenized lung tissue was standard-
ized by lung tissue weight. LPS induced
neutrophil emigration (*P  0.01), which
was attenuated by Y-27632 pretreatment
(#P  0.05).
Figure 3. Circulating neutrophil count. Blood samples were obtained
from the orbital sinus (time 0 and 15 min) and inferior vena cava (6 h).
Regardless of Y-27632 treatment, mice administered LPS revealed a
significant decline of neutrophil count (*P  0.01). At 6 h, neutrophil
count in LPS-treated mice was increased compared with that at 15 min,
but was still less than that in mice without LPS administration. Pretreat-
ment with Y-27632 made no difference to the neutrophil count regard-
less of LPS challenge (n 	 8 in each group).
phils, 44.3  3.8% of neutrophils had F-actin rims beneath the
plasma membrane. After fMLP stimulation for 2 min, this per-
centage increased to 79.3  11.0%. Pretreatment with Y-27632
caused no significant change in this actin remodeling event in-
duced by fMLP. There was also no significant difference in the
appearance of this F-actin rim between the groups without fMLP
stimulation with or without Y-27632 pretreatment. Confocal
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TABLE 1. NEUTROPHILS WITH F-ACTIN RIM APPEARANCE (%)
fMLP (min)
PBS 0.5 2 5
Control 44.3  3.8 78.0  8.8* 79.3  11.0* 88.7  2.8*
Y-27632 38.7  5.6 81.3  2.6* 87.3  1.5* 90.7  1.3*
Definition of abbreviations: fMLP, formyl-methionyl-leucyl-phenylalanine; PBS,
phosphate-buffered saline.
Stimulation with fMLP rapidly increased neutrophils with an f-actin rim appear-
ance. Treatment with Y-27632 made no difference to the fraction of neutrophils
with an f-actin rim. Values are mean  SEM (n 	 3).
microscopy revealed no differences in the structure of the F-actin
rim with or without Y-27632 pretreatment (data not shown).
Albumin Leakage through Endothelial Cell Monolayer
Changes in the permeability of an endothelial monolayer, which
was evaluated after 6 or 24 h of stimulation by measuring albumin
transfer, are shown in Figures 4A and 4B, respectively. Com-
pared with the control, 6 h stimulation with TNF- at a concen-
tration of 102 U/ml caused a significant increase in the albumin
concentration in the lower chamber (P  0.001) (Figure 4A).
In the groups with Y-27632 pretreatment at concentrations of
1, 10, and 100 M, the albumin concentrations of the lower
Figure 4. Permeability of endothelial monolayer determined by albu-
min transfer. TNF- (102 U/ml) significantly increased the permeability
either after 6 or 24 h, compared with the control (*P  0.001). (A )
Treatment with 1, 10, and 100 M Y-27632 significantly inhibited the
increase in the permeability that was induced by 6 h stimulation with
TNF- (#P  0.01), whereas 0.1 M Y-27632 failed to attenuate the
damage. (B ) The increase in the permeability of endothelial monolayer,
which was induced by 24 h stimulation with TNF-, was completely
inhibited by the Y-27632 (1, 10, 100 M) pretreatment (#P  0.01).
Pretreatment with 0.1 M Y-27632 caused no significant attenuation
of the increased permeability of endothelial monolayer.
chamber were significantly lower than in the TNF- control
group (P  0.01). There was no significant difference in the
albumin concentration of the lower chamber between the TNF-
control group and those with Y-27632 pretreatment at concentra-
tion of 0.1 M, which indicates that the increase in albumin
transfer induced by TNF- stimulation for 6 h might be attenu-
ated only by the higher concentration of Y-27632. At 24 h, TNF-
also induced a significant increase in the albumin concentration,
compared with the control (P  0.001). Treatment with Y-27632
at concentrations of 1, 10, and 100 M significantly inhibited
the increase in albumin transfer induced by 24 h stimulation
with TNF- (P  0.01), although 0.1 M of Y-27632 made no
significant difference in the albumin concentration of the lower
chamber (Figure 4B). Y-27632 itself did not induce a change in
albumin transfer either at 6 or 24 h. These results suggest that
treatment with Y-27632 at concentrations of 1 M or higher may
be protective against endothelial damage induced by TNF-.
Morphologic Changes in Endothelial Cell Monolayer
Rhodamine-phalloidin staining of monolayers was performed
to permit visualization of actin filaments. Control cells showed
characteristic peripheral bands and close cell–cell contact (Figure
5A). Treatment with TNF- at concentration of 103 U/ml caused
a significant change in this pattern. TNF- treatment resulted
in the development of randomly oriented stress fibers, disappear-
ance of peripheral bands, cell retraction, and intercellular gaps
(Figure 5B). Pretreatment with Y-27632 (100 M) prevented
the changes caused by exposure to TNF- (Figure 5C).
DISCUSSION
This study revealed that pretreatment with Y-27632 attenuated
lung edema formation and neutrophil emigration after intrave-
nous LPS. Although Y-27632 caused no change in fMLP-induced
cytoskeletal rearrangement in neutrophils, morphologic changes
in endothelial cells after TNF- stimulation were inhibited by
Y-27632 treatment. The TNF-–induced increase in albumin
leakage through an endothelial monolayer was also attenuated
by treatment with Y-27632. These results suggest a possible
contribution of Rho/ROCK to the pathogenesis of LPS-induced
acute lung injury.
LPS-induced lung injury is known to be neutrophil-dependent
(3, 4). Intravenous or intratracheal challenge of inflammatory
stimuli, such as LPS, has been shown to cause sequestration
and subsequent emigration of neutrophils, which produce tissue
injury by releasing various mediators and oxygen radicals (4).
Rapid sequestration of neutrophils into the lung microvascula-
ture after intravenous LPS administration is believed to depend
on cell stiffening caused by the cytoskeletal rearrangement of
neutrophils, whereas various adhesion molecules contribute to
subsequent firm adhesion between neutrophils and endothelial
cells (4). This study determined whether the effects of Y-27632
occurred through inhibition of neutrophil sequestration by pre-
venting the formation of F-actin rims induced by mediators asso-
ciated with gram-negative sepsis. Stimulating neutrophils with
fMLP increases their F-actin content rapidly within the periphery
of the neutrophils by 2 min, resulting in neutrophil stiffening
(26–28). In the present study, F-actin formation in human neutro-
phils was examined by staining with rhodamine-phalloidin, and
an increase in the percentage in neutrophils containing F-actin
rims was observed after fMLP stimulation. Although Y-27632
clearly modulates cytoskeletal rearrangements in smooth muscle
cells and endothelial cells (17, 29), our observations revealed
that Y-27632 did not alter the rapid submembrane formation
of F-actin in nonadherent neutrophils stimulated with fMLP.
Y-27632 also had no significant effect on the circulating neutrophil
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Figure 5. Rhodamine-phalloidin staining of endothelial cell monolayer.
(A ) Control cells showing characteristic peripheral bands and close
cell–cell contact. (B ) Cells treated with TNF- (103 U/ml) revealing
development of randomly oriented stress fibers, disappearance of pe-
ripheral bands, cell retraction, and intercellular gaps. (C ) Pretreatment
with Y-27632 (100 M) prevented the changes induced by TNF-.
Original bar, 20 m.
counts in uninjured mice and had no effect on the LPS-induced
decrease in counts, suggesting that Y-27632 does not cause a
significant increase in neutrophil stiffness or in neutrophil se-
questration. Thus, the Rho/ROCK pathway does not appear to
mediate neutrophil sequestration.
Following sequestration, however, many complex cytoskeletal
events occur that mediate adhesion and crawling of neutrophils
along endothelial cells and into the lung tissue. For example,
activation of RhoA and ROCK is essential for de-adhesion or
detachment of already adherent leukocytes (30, 31). Leukocytes
pretreated with Y-27632 demonstrated impaired de-adhesion,
which could be responsible for attenuated transmigration through
the endothelium (30, 31). Although the effect of Y-27632 on
leukocyte de-adhesion was not examined in this study, impair-
ment of this process or others might be a mechanism for the
attenuation of lung injury that we observed in animals treated
with Y-27632.
The protective effect of Y-27632 on endothelial cells may be
responsible for the attenuation of lung injury. To examine this
hypothesis, the effect of Y-27632 on endothelial cell damage
induced by TNF- was evaluated using cultured endothelial cell
monolayers. TNF- increased permeability through the mono-
layer, as estimated by albumin transfer, and induced actin re-
modeling visualized by rhodamine-phalloidin staining of the
monolayer. Pretreatment with Y-27632 significantly inhibited
these changes, suggesting that the Rho/ROCK pathway mediates
these TNF- effects.
The molecular motor that drives nonmuscle actin cytoskeletal
rearrangement is the myosin II–associated ATPase, which gener-
ates mechanical force by promoting the translational cross-
bridge movement of myosin heads across the actin fibers. This
process is regulated by the phosphorylation of myosin light chain
(MLC) catalyzed by the Ca2
/calmodulin-dependent MLC ki-
nase (MLCK). MLC phosphorylation triggers myosin ATPase
activity and actin polymerization and is essential to smooth mus-
cle and nonmuscle tension development. Rho kinases increase
MLC phosphorylation via inhibition of the regulatory subunit of
the myosin-specific phosphatase, and inhibition of Rho-ROCK
pathway decreases MLC phosphorylation (32). Petrache and
colleagues reported that reduction in MLC phosphorylation by
the inhibition of either MLCK or ROCK attenuated TNF-
–induced stress fiber formation (33). In their study, however,
ROCK inhibition did not attenuate TNF-–induced endothelial
barrier dysfunction measured by transcellular electrical resis-
tance. In contrast, our studies demonstrated a complete inhibi-
tion of the TNF-–induced increase in permeability to albumin
by the ROCK inhibitor. The most interesting and likely interpre-
tation for these discrepant results in the role of ROCK in endo-
thelial barrier function is that ROCK is required for disruption
of permeability to protein, but decreases in electrical resistance
can occur through ROCK-independent mechanisms. Other dif-
ferences in the details of the studies may also contribute to the
apparent discrepancy.
Because our in vitro study suggests that the inhibition of
Rho/ROCK pathway protects against TNF-induced endothelial
damage, the attenuation of the LPS-induced increase in EVA
by Y-27632 observed in vivo may be due to an important role
of this signaling pathway in endothelial cells of the pulmonary
microvasculature. Saito and colleagues demonstrated that pre-
treatment with Y-27632 significantly attenuated leukotriene B4–
induced actin polarization in endothelial cells (29). Furthermore,
although Y-27632 had no effect on the number of adherent
neutrophils, neutrophil transmigration through endothelial cell
monolayers was less when cells were pretreated with Y-27632
(29). Although we did not conduct a directly relevant experiment
such as evaluation of neutrophil transmigration, the results of
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the present study, combined with previous findings, suggest that
the Rho/ROCK pathway may be important in neutrophil migra-
tion or transendothelial cell migration, rather than neutrophil
sequestration into the lung microvasculature. It remains to be
determined whether Rho/ROCK inhibition modulates the func-
tion of neutrophils, endothelial cells, or both.
In the present study, we observed a significant decrease in
the circulating neutrophil counts after LPS injection. Although
in rats, rabbits, and guinea pigs, an intravenous challenge of
LPS or other inflammatory mediators causes a rapid decline
in circulating neutrophil count, there have been few reports
describing neutrophil counts after inflammatory stimuli in mice
(3, 34–36). Recently, Andonegui and colleagues reported a sig-
nificant decrease in circulating leukocyte count 30 min after
intraperitoneal administration of LPS in C57BL/6 mice (37).
They also described LPS-induced neutrophil sequestration into
the lungs, which was determined by MPO level in lung tissue
(37). Although they did not present data describing circulating
neutrophils, and our study did not quantitate neutrophil seques-
tration at early time points when the circulating neutrophil
counts are low, this fall in circulating neutrophil counts likely
reflects LPS-induced sequestration of neutrophils in the lungs.
As an inflammatory stimulus, we chose LPS for the murine
model of acute lung injury, fMLP for neutrophil cytoskeleton
observation, and TNF- for endothelial monolayer studies. Be-
cause endotoxemia is known to be one of major predisposing
factors of ARDS, LPS is widely used in animal models of experi-
mental lung injury. In the present study, therefore, we used LPS
to induce acute lung injury in mice so that we can compare the
results with those from other studies. On the other hand, previ-
ous works suggest that the onset of neutrophil stiffening induced
by fMLP and by LPS may differ. For example, whereas Saito
and colleagues reported that neutrophil stiffness is rapidly (i.e.,
within 30 s) increased after fMLP stimulation (34), Erzurum and
colleagues revealed that LPS-induced neutrophil stiffness takes
10–30 min (38). Because the LPS-induced neutrophil stiffening
takes a wide range of time, we thought it could be difficult
to set a time point to estimate percentage of neutrophils with
cytoskeletal rearrangement and, therefore, chose fMLP, which
induces neutrophil stiffening readily within a minute, as a stimu-
lus. Concerning the endothelial monolayer experiment, we per-
formed a preliminary experiment using LPS as a stimulant (data
not shown) and observed that LPS-induced changes in the per-
meability of endothelial monolayer were relatively irreproduci-
ble. In the endothelial monolayer experiments, therefore, we
chose TNF-, which caused endothelial damage reproducibly,
as a stimulant.
Pretreatment with Y-27632 significantly attenuated lung
edema and neutrophil emigration in LPS-induced lung injury in
mice, but it failed to reveal complete inhibition of lung injury.
It was suggested that, even if this compound can be applicable
as therapeutic modality for ARDS, its protective effect may be
modest or limited. In addition, although we observed no symp-
tom suggesting systemic hypotension in this study, it has been
reported that Y-27632 inhibits smooth-muscle contraction and
corrects the blood pressure of hypertensive rat models (17).
When clinical application of Rho/ROCK inhibitor is considered,
it should be necessary to preclude its possible detrimental effects
(such as hypotension) and to assess the efficacy of Rho/ROCK
pathway inhibition in established acute lung injury, not merely
as a pretreatment.
In conclusion, Y-27632 attenuates LPS-induced acute lung
injury, both the edema formation and the emigration of neutro-
phils. These effects are unlikely to be modulated through a role
for the Rho/ROCK pathway in neutrophil sequestration. Rather,
this compound may be acting through effects on modulating
endothelial cell damage induced by inflammatory stimuli. Y-27632
may have potential as a therapeutic modality for acute lung injury.
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